دورية أكاديمية
Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients
| العنوان: | Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients |
|---|---|
| المؤلفون: | Yuan, Shumin, Peng, Ling, Liu, Yuqing, Till, Brian G., Yan, Xiang, Zhang, Jie, Zhu, Liping, Wang, Huijuan, Zhang, Shaokai, Li, HongleAff9, IDs00262022032595_cor10, Gao, QuanliAff1, IDs00262022032595_cor11, Wang, ZibingAff1, IDs00262022032595_cor12 |
| المصدر: | Cancer Immunology, Immunotherapy. 72(2):437-448 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 03407004 14320851 |
|---|---|
| DOI: | 10.1007/s00262-022-03259-5 |